Company: Integrated Diagnostics Holding
It has been a busy time for Dr Hend El Sherbini – CEO of Integrated Diagnostics Holding.
In December last year, private equity firm Actis announced an investment for 21 percent of IDH – the largest private sector healthcare diagnostics service provider in Egypt.
The stake was sold by UAE’s Abraaj, and a month later IDH announced plans to list on the London Stock Exchange, targeting a value of around $600 million.
IDH was created in 2012 as a merger of Al Mokhtabar and Al Borg Laboratories. It offers pathology and molecular diagnostics, genetics testing and basic radiology in Egypt, Jordan and Sudan, operating hundreds of laboratories, treating nearly six million patients, and conducting more than 19 million tests per year.
Discussing the proposed IPO, El Sherbini said: “As we continue to build on our success to date, reflecting years of profitable growth, high margins and operational excellence, we believe IDH represents a highly attractive future growth story. This initial public offering is a pivotal next step for us that will allow us to further accelerate our market penetration and expand our service offerings.”